NKTR and pancreatic neoplasm: Rastelli L, Gupta S, Dahiya A, Jagga Z, Nandabalan K, Upmanyu S. Efficacy and immune modulation by BXCL701 a dipeptidyl peptidase inhibitor, NKTR-214 a CD122-biased immune agonist with PD1 blockade in murine pancreatic tumors.